Patients with unexplained physical symptoms have poorer quality of life and higher costs than other patient groups: a cross-sectional study on burden

BMC Health Services Research
Lyonne N L ZonneveldJan J V Busschbach

Abstract

To determine whether healthcare resources are allocated fairly, it is helpful to have information on the quality of life (QoL) of patients with Unexplained Physical Symptoms (UPS) and on the costs associated with them, and on how these relate to corresponding data in other patient groups. As studies to date have been limited to specific patient populations with UPS, the objective of this study was to assess QoL and costs in a general sample of patients with UPS using generic measures. In a cross-sectional study, 162 patients with UPS reported on their QoL, use of healthcare resources and lost productivity in paid and unpaid work. To assess QoL, the generic SF-36 questionnaire was used, from which multidimensional quality-of-life scores and a one-dimensional score (utility) using the SF-6D scorings algorithm were derived. To assess costs, the TiC-P questionnaire was used. Patients with UPS reported a poor QoL. Their QoL was mostly decreased by limitations in functioning due to physical health, and the least by limitations in functioning due to emotional problems. The median of utilities was 0.57, and the mean was 0.58 (SD = .09).The cost for the use of healthcare services was estimated to be €3,123 (SD = €2,952) per patient per ...Continue Reading

References

Sep 1, 1992·General Hospital Psychiatry·K M RostG R Smith
Dec 1, 1989·Controlled Clinical Trials·R JaeschkeG H Guyatt
May 1, 1984·Comprehensive Psychiatry·W KatonA Kleinman
Jun 7, 1992·PharmacoEconomics·J T OsterhausJ R Plachetka
Jul 31, 1999·Comprehensive Psychiatry·G GaryfallosE Dimitriou
Feb 19, 2000·International Journal of Cancer. Supplement = Journal International Du Cancer. Supplement·D Osoba
Sep 27, 2000·Journal of Clinical Epidemiology·M A SprangersH C de Haes
Jul 13, 2001·Journal of Psychosomatic Research·C NimnuanS Wessely
Aug 10, 2001·Psychosomatics·R NoyesS L Longley
Apr 10, 2002·Journal of Health Economics·John BrazierMark Deverill
Jun 28, 2003·International Journal of Methods in Psychiatric Research·Kurt Kroenke
Jul 29, 2003·Psychosomatic Medicine·Peter HenningsenHeribert Sattel
Mar 16, 2004·Journal of Psychosomatic Research·Max Henderson, Charles Tannock
Jun 3, 2004·The British Journal of Psychiatry : the Journal of Mental Science·Margot W M de WaalAlbert M van Hemert
Jun 15, 2004·Journal of Occupational and Environmental Medicine·Christopher J Evans
Jun 24, 2004·Cost Effectiveness and Resource Allocation : C/E·Kenneth J ReynoldsWilliam C Reeves
Sep 14, 2004·Health Economics·John BrazierJan Busschbach
Oct 2, 2004·Acta Psychiatrica Scandinavica·L Hakkaart-van RoijenF F H Rutten
Jan 28, 2005·Psychosomatic Medicine·Robert C SmithJohn Goddeeris
May 19, 2005·Journal of Personality Disorders·Giuseppe MainaFilippo Bogetto
Aug 3, 2005·Archives of General Psychiatry·Arthur J BarskyDavid W Bates
Aug 23, 2005·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Stephen J Walters, John E Brazier
Oct 18, 2005·Health Policy·Elly A StolkJan J V Busschbach
Apr 25, 2006·Family Practice·Peter F M VerhaakGerrit Wolters
Jun 2, 2007·Journal of Psychosomatic Research·Javier Garcia-CampayoAida Pascual
Sep 28, 2007·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Hèlene KochPatrick J E Bindels
Dec 7, 2007·The British Journal of Psychiatry : the Journal of Mental Science·Richard MorrissLinda Gask
Jan 29, 2008·Journal of Psychosomatic Research·Faruk UguzErtan Yilmaz
Feb 22, 2008·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Joern Moock, Thomas Kohlmann
Mar 28, 2008·The Journal of Clinical Psychiatry·Djøra I SoetemanJan J V Busschbach
Apr 25, 2008·General Hospital Psychiatry·Bernd LöweKurt Kroenke
Aug 14, 2008·The British Journal of Psychiatry : the Journal of Mental Science·A SumathipalaA H Mann
Dec 4, 2008·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·Nick KontodimopoulosDimitris Niakas
Jun 30, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Nick KontodimopoulosDimitris Niakas
Apr 2, 2010·The British Journal of Psychiatry : the Journal of Mental Science·Anna FernándezUNKNOWN DASMAP investigators

❮ Previous
Next ❯

Citations

May 18, 2016·Psychosomatic Medicine·Anne van GilsJudith G M Rosmalen
Sep 17, 2016·SAGE Open Medicine·Kimberley LeeFrederick Sundram
Jun 1, 2018·Journal of Occupational and Environmental Medicine·Alix Félin-GermainGuillaume Foldes-Busque
Oct 16, 2018·PloS One·Margreet S H WortmanTim C Olde Hartman
Nov 17, 2019·Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation·P E van WestrienenC Veenhof
Jan 23, 2021·Clinical Medicine : Journal of the Royal College of Physicians of London·Jessica A Eccles, Kevin A Davies
Jul 18, 2018·Psychiatry Research·Madelon M E RiemEugenie Beijer
Nov 25, 2020·Journal of Psychosomatic Research·R N GroenJ G M Rosmalen
Oct 16, 2021·Acta Odontologica Scandinavica·Admassu N LamuLars Björkman

❮ Previous
Next ❯

Software Mentioned

TiC

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.